Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$498,000.00
May 1, 2025
For-profit organization
UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles
1032265
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine.
$514,123.00
Apr 1, 2025
For-profit organization
UK Biomanufacturing - 10141267 - BPE Human Vaccines - Implementation of High Yielding Plasmid DNA Platform for Human Vaccine Manufacturing
1028954
This project leverages the combined vaccine development platform technologies of Pegasus Biotech, ConserV Bio and 4BaseBio to evaluate and enhance the manufacturing capability of a novel Canadian plasmid DNA technology platform (BPE) in the production of a new class of human influenza vaccines based on ConserV Bio's FLU-v technology.
$547,944.00
Apr 1, 2025
For-profit organization
UK - Biomanufacturing - 10143729 - Heterologous Prime-boost Vaccination Induces Anti-tumor Immunity Against Melanoma.
1029005
“As part of the international consortium project “Cancer Immunotherapy: Heterologous prime-boost vaccination induces anti-tumor immunity against melanoma”, this project will …*
The firm will develop a novel immunotherapy to improve treatment options and prevent mortality and morbidity from advanced melanoma.
$49,900,000.00
Mar 7, 2025
For-profit organization
Project Bedrock
819532
These two biomanufacturing Good Manufacturing Practices (GMP) facilities will be established to enable the production of essential Messenger Ribonucleic Acid (mRNA) vaccines, viral diagnostics and antibody therapeutic inputs at a large scale of up to 5000 litres per batch.
$4,000,000.00
Mar 6, 2025
Not-for-profit organization or charity
Polio eradication in Afghanistan
7465972 P014097001
A significant number of Afghan children remain unvaccinated, and this project aims to increase polio vaccine campaign activities for Afghan children under the age of 5.
$4,000,000.00
Feb 26, 2025
Not-for-profit organization or charity
Polio eradication in Afghanistan
7465974 P014097002
A significant number of Afghan children remain unvaccinated, and this project aims to increase polio vaccine campaign activities for Afghan children under the age of 5.
$75,000.00
Nov 1, 2024
For-profit organization
MNC Collab - IEVSSP - IAVI Elarex VSV Stability Study POC
1023443
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.
$204,387.00
Sep 5, 2024
Not-for-profit organization or charity
Non-Viral Gene Therapy for Myotubular Myopathy: Skeletal Muscle Targeted
Lipid Nanoparticle-Mediated Delivery of the MTM1 Gene to Restore Muscle
Function.
1025235
Lipid nanoparticles
(LNPs), successful in mRNA vaccine delivery, offer a promising non-viral
alternative.
$697,950.00
Aug 1, 2024
Not-for-profit organization or charity
Moving Foreign Animal Disease Preparedness Forward for African Swine Fever and Foot and Mouth Disease
FAP 2324-005
This project is comprised of five distinct sub-projects, each contributing to the overall objective of enhancing Canada’s preparedness for foreign animal disease incursions, specifically African swine fever (ASF) and foot and mouth disease (FMD):
Sub-project 1: CanSpotASF Epidemiologic Surveillance Analysis
Sub-project 2: ASF Large-Scale Depopulation Training Project
Sub-project 3: ASF/FMD - Defining Federal, Provincial and Territorial Governments and Industry Partners (FPTI) Roles and Responsibilities Project
Sub-project 4: Foot and Mouth Vaccine Strategy Preparedness Efforts - Phase 1
Sub-project 5: African Swine Fever and Foot and Mouth Disease Exercises and Drills
$555,000.00
Aug 1, 2024
Not-for-profit organization or charity
Canada's assessed contribution to the World Customs Organization
7461280 P005333001
The World Customs Organization (WCO) is an independent intergovernmental body whose mission is to enhance the effectiveness and efficiency of customs administrations. The WCO currently has 177 member governments. A member of the WCO, Canada has taken a key role in areas such as trade facilitation, revisions to the Harmonized System, capacity building, combating counterfeiting and the development and implementation of the Framework of Standards to Secure and Facilitate Global Trade (SAFE). Canada’s contribution to the WCO advances its interests internationally, particularly given the importance of international trade for the Canadian economy.